{"id":3749,"date":"2026-05-11T19:03:00","date_gmt":"2026-05-11T17:03:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=e9bd4a8ce2d6647f9847bb2278672dcb"},"modified":"2026-05-11T19:03:00","modified_gmt":"2026-05-11T17:03:00","slug":"milecell-biotechnology-launches-new-corporate-website-appoints-nianwei-lin-phd-as-ceo-and-wayne-vaz-as-cco","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=3749","title":{"rendered":"MileCell Biotechnology Launches New Corporate Website, Appoints Nianwei Lin, PhD, as CEO and Wayne Vaz as CCO"},"content":{"rendered":"

SAN DIEGO--(BUSINESS WIRE)--MileCell Biotechnology (\u201cMileCell\u201d) today announced the launch of its newly redesigned website www.milecell-bio.com<\/a>, delivering an enhanced digital experience for researchers and industry partners worldwide. The company also announced the appointments of Nianwei Lin, PhD, Chief Executive Officer and Wayne Vaz, Chief Commercial Officer.<\/p><\/a><\/a>

\nThe new website was developed to improve usability, streamline product discovery, and provide researchers with easier access to technical resources supporting ADME, DMPK, toxicology, and cell therapy R&D applications. Key enhancements include intuitive navigation, expanded scientific content, improved global search, integrated quotation and shopping cart functionality, and a significantly expanded Resource Hub featuring publications, application notes, certificates of analysis (COAs), technical documentation, and quality system and compliance.<\/p>

\n\u201cOur new website reflects MileCell\u2019s commitment to providing a more efficient and informative user experience,\u201d said Nianwei Lin, PhD, CEO of MileCell. \u201cAt the same time, we are strengthening our leadership team to drive the company\u2019s next phase of global growth and customer engagement.\u201d<\/p>

\nDr. Lin brings extensive experience in biotechnology industry leadership and scientific innovation. As CEO, he will lead MileCell\u2019s corporate strategy, operational execution, and global expansion initiatives.<\/p>

\nWayne Vaz joins MileCell as Chief Commercial Officer driving corporate expansion, channel partner strategy and market development initiatives. Vaz brings deep expertise in commercializing technologies, products and services for life science industry research and bioproduction, corporate development and growth.<\/p>

\n\u201cOur products and services are vital to supporting growing market demand for cell-based assay systems and new approach methodologies (NAMs) that replace or augment animal-based models,\u201d said Vaz.<\/p>

\nThe new website is now live and accessible to customers worldwide.<\/p>

\nAbout MileCell Biotechnology<\/b><\/p>

\nMileCell Biotechnology<\/a> is a provider of high-quality biological products and research solutions supporting ADME, DMPK, toxicology, and cell therapy research. The company offers a broad portfolio of primary cells, subcellular fractions, biological matrices, media, reagents, and scientific support resources for pharmaceutical, biotechnology, and academic research customers.<\/p>

\nMileCell's operations are supported by internationally recognized management systems, including ISO 9001:2015 Quality Management, ISO 14001:2015 Environmental Management, ISO 45001:2018 Occupational Health & Safety Management and U.S-FDA Type II DMF. These certifications ensure that MileCell maintains high standards for product quality, environmental responsibility, and workplace safety. To learn more, please visit www.milecell-bio.com<\/a>. Follow MileCell Biotechnology on LinkedIn<\/a>, and YouTube<\/a>.<\/p> Contacts<\/b>

\nMedia Contact<\/b>Wayne Vaz\nChief Commercial Officer\nwayne.vaz@milecell-bio.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–MileCell Biotechnology (\u201cMileCell\u201d) today announced the launch of its newly redesigned website www.milecell-bio.com, delivering an enhanced digital experience for researchers and industry partners worldwide. The company also…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3749","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/3749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3749"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/3749\/revisions"}],"predecessor-version":[{"id":3750,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/3749\/revisions\/3750"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}